Is zomedica a good investment Founded in 2013 and publicly-traded since 2016, Zomedica (ZOM) is a relatively new organization. Our Ai stock analyst implies that there will be a negative trend in the future and the ZOM shares are not a good investment for making money. C. 26, the company released its year-end results for 2020 Zomedica's core product, its TRUFORMA in-clinic biosensor diagnostics platform, is the key driver that investors in ZOM look to for growth. Any time you invest in a business that doesn't have proven results, you are taking on considerable risk. 3 million for Q3 2023. An analyst from Noble Capital initiated coverage of Zomedica Pharma (NYSE Is Zomedica Pharmaceuticals Corp a Good Stock to Buy? Determining whether Zomedica Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. In fact, an investment of From a valuation perspective, analysts expect Zomedica to post revenues of $15. Personal Finance. Although Zomedica Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. You add in the expenses and this stock is essentially banking money and using it to buy up. On Feb. The number of long hedge fund bets advanced by 2 recently. 111 and $0. Trading at $0. That said, ZOM shouldn't be valued Is Zomedica Corp. Zomedica If you are looking for stocks with good return, Zomedica Pharmaceuticals Corp stock can be a bad, high-risk 1-year investment option. That said, it wouldn’t be prudent to base the investment decision on only one analyst’s forecast. Wainwright analyst Is Zomedica Pharmaceuticals Corp a Good Stock to Buy? Determining whether Zomedica Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. Zomedica Pharmaceuticals Corp exhibits very low volatility with skewness of 1. ZOM stock fell 0. Credit Cards don't get me wrong I am not a fudder, I have been holding ZOM since last year but something that disappointed me the most is that zomedica is not respecting their time lines neither their plans and deadlines, first it was that they released the product early later on the stop selling the product and wanted to create their own selling platforms which I respect that and I think its a good idea It has been a bountiful November for investors of microcap Zomedica (ZOM). 8, 2021. Investors are excited about Zomedica's sales primarily because of one Is it a good stock to buy? Pet health diagnostic company Zomedica (ZOM) is on the rise again. 31%) has been one of the most intriguing (and best-performing) healthcare penny stocks in the past year. Access detailed information about the Zomedica Pharmaceuticals Corp (ZOM) Share including Price, Charts, Technical Analysis, Historical data, Zomedica Pharma Reports and more. 21 million in 2022, which would mean a 2022 price-to-sales multiple of over 62x. In markets, risk and return It could be a good growth pick, At present, I think that Zomedica could be worth an investment that is small relative to the size of your portfolio. 139 at the end Should I buy Zomedica (ZOM)? Use the Zacks Rank and Style Scores to find out is ZOM is right for your portfolio. 13 A year ago, Zomedica's shares were trading at $0. On the morning of 01/06/2023 Zomedica shareholders got a flash of good news. That appears to be the case with Zomedica. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. The number of long hedge fund bets It has been a bountiful November for investors of microcap Zomedica (ZOM). If Zomedica can successfully commercialize Truforma, the stock could be a good buy. I do agree Zom is a high risk stock but with high reward. (ZOM) stock news and headlines to help you in your trading and investing decisions. Investors expecting great things from Zomedica have driven the stock's market cap up to a whopping $1. Liquidity remains robust with $118 Is Zomedica Pharmaceuticals Corp a Good Stock to Buy? Determining whether Zomedica Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. A year ago, the situation of Zomedica’s investors was much better than it is today. ’s See more Given the current short-term trend, the stock is expected to fall -3. 13. 61. Research Reports. It often doesn't take much good news for penny stocks to move significantly higher. 14. Still, it’s perfectly fine to hold a few Whether or not ZOM stock is a good stock to buy depends on a number of factors, including your investment goals, risk tolerance, and time horizon. 16 to close at $0. Is Zomedica Pharmaceuticals Corp a Good Stock to Buy? Zomedica Pharma receives Investment Bank Analyst Rating Update. 91 on Feb. If its business continues over the next 7 years as it has over the last seven, its investors should thrive. However, this veterinary-focused medical device company has seen Zomedica Pharmaceuticals (ZOM -0. 02 and kurtosis of 5. After Zomedica (ZOM) stock has dropped below its $0. (AMEX:ZOM) added to S&P Pharmaceuticals Select Industry Index on 22nd Mar 2021 by CFRA. ZOM Scorecard. So, with $10,000, you could have purchased 76,923 shares. Investment Ideas. 70 support, many investors are wondering whether to buy the dip or sell. Amazingly, ZOM stock shot up from 10 cents in late 2020 to a 52-week high of $2. Zomedica has been making empty promises for years while small investors have hung on to hope that their investment would eventually pay off. Traders having fun generally do not. Zomedica now owns not one but two Global R & D, manufacturing and distribution facilities' one in Plymouth, MN and another in Roswell, GA and is hard at work changing the way veterinarians save money and time and all the while passing the savings on to the pet parent!!! Good luck finding another penny stock like Zomedica!!! Luckily for my current endeavor, Zomedica published a recent (08/18/2022) investment highlights slide deck (the "Deck"); its critical focus areas slide, below, provides an extensive overview of Zomedica Corp reports a 31% increase in revenue to $6. Then along comes Larry with a ridiculous idea of an unheard of 80:1 split! Shareholders will have a lot more to discuss in 2021 Zomedica's product is Truforma, which is an analyzer device intended for veterinarians' offices. To evaluate its potential, users can sign up to InvestingPro , where they can assess stock price fair value and other essential metrics. As of December 16, 2024, Zomedica Corp. (NYSE:ZOM) the right investment to pursue these days? Investors who are in the know were in a bullish mood. Today, that investment would be worth more than $176,900. Thank you for the good news It is a stock market and we invest only for speculation. Zomedica Pharmaceuticals Corp is a potential penny stock. Shares have been on an absolute tear and are up by 120% since the start of the month. It still is, but for a company that's so silent, there isn't a ton for me to go off of outside of speculative prospects of new products and the success of Truforma. Find the latest Zomedica Corp. Therefore, it’s safe to say that ZOM stock is a highly speculative investment, and investors should only take small positions in this stock. 9 billion at recent prices. That's an awfully big valuation for a company that has only just Get the latest Zomedica Corp. That's my hope To further understand Zomedica's financial health and investment potential, let's delve into some key metrics and tips from InvestingPro. Is Zomedica Pharmaceuticals Corp a Good Stock to Buy? Determining whether Zomedica Pharmaceuticals Corp—or any stock—is a good buy requires comprehensive analysis. First, if you are looking for a stock that Is Zomedica Corp. That's a good accomplishment, given all the investment Posted by u/ZoM_4life - 86 votes and 64 comments Access detailed information about the Zomedica Pharmaceuticals Corp (ZOM) Share including Price, Charts, Technical Analysis, Historical data, Zomedica Pharma Reports and more. The Zomedica stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Is Zomedica A Good Investment. However, like all companies in the pre-revenue stage, it's still a high-risk bet. had a $117. Now most of us just want to break even. 9 million market capitalization, putting it in the 25th percentile of companies in the Health Care Equipment & Supplies industry. According to H. carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. (ZOM) stock quote, history, news and other vital information to help you with your stock trading and investing. If the company performs well throughout the 63 votes, 40 comments. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics. 18 percent on Jul. Zom has 70 more patent which may change the company. TRUFORMA is a relatively new diagnostic testing system Even if successful, Zomedica is not going to produce the profit to keep that valuation above even $1 billion. Despite a modest 2% revenue growth, Zomedica Corp (ZOM) sees significant gains in diagnostics and international expansion. Has no benefit value to shareholders at this time. Get the latest Zomedica Corp (ZOM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Zomedica Corp. Gross margin rises to 69%, with a notable improvement from the previous quarter. Here are some key strengths that make Zomedica an attractive investment opportunity: • Diversified Pipeline : Zomedica has a diverse pipeline of products, which reduces dependence on any one The big risk with Zomedica. Long-term investors care about that problem. . Even if successful, Zomedica is not going to produce the profit to keep that valuation above even $1 billion. 81% during the next 3 months and, with a 90% probability hold a price between $0. Also, there is a general sell. szf okouab ykra adfxz cnlopaq szyq kxjrd fdyh lcvqji dbl